The mechanism by which muscle converts chemical energy in the form of adenosine triphosphate (ATP) into mechanical energy as work, force and shortening (chemomechanical transduction) will be studied. Current theories of chemomechanical transduction are based on kinetic analyses of the ATPase of isolated muscle proteins in solution and mechanical measurements on muscles cells. These theories require that the rate of ATP hydrolysis is regulated by how fast the muscle shortens or lengthens and assume that the rate at which ATP hydrolysis products, inorganic phosphate (Pi) and adesoine diphosphate (ADP), are released by the crossbridges is determined by the the force or displacement applied to the crossbridges. The rate of ATP is hydrolysis by shortening or lengthening mammalian muscles and whether force or displacement affects the rate of product release by the crossbridge are not known. The development of 2-nitro benzyl derivates of ATP, ADP, and Pi, which can rapidly (greater than 100 s-1) photogenerate ATP, ADP, or Pi allows measurement of the rate of ATP hydrolysis and, by employing transient kinetic techniques, the rate constants for Pi and ADP release and binding in single glycerinated muscle fibers. The studies described in this application are designed to experimentally measure the influence velocity of shortening and lengthening have on the rate of ATP hydrolysis, the efficiency of work performance, and product release rate constants in single glycerinated muscle fibers. In theories of contractile regulation, the force development and actomyosin ATPase rate are controlled by the sarcoplasmic calcium concentration by either a steric blocking mechanism or modulation of the rate of Pi release from the actomyosin-products complex. Both mechanisms predict that the isometric force and ATPase rate should rise in parallel with increases in the sarcoplasmic calcium concentration. This hypothesis, as well as the effect of calcium concentration on the rate of Pi release from the crossbridge, will be examined in glycerinated muscle fibers are proposed in which the minimum distance a crossbridge can remain attached to the thin. These simultaneous measurements of mechanical behavior and chemical change in a system whose structural integrity and mechanical restrains are preserved and under direct experimental control, permits rigorous testing of current theories of contraction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR030988-10
Application #
3155946
Study Section
General Medicine B Study Section (GMB)
Project Start
1982-05-01
Project End
1992-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Siththanandan, V B; Tobacman, L S; Van Gorder, N et al. (2009) Mechanical and kinetic effects of shortened tropomyosin reconstituted into myofibrils. Pflugers Arch 458:761-76
Sumandea, Marius P; Vahebi, Susan; Sumandea, C Amelia et al. (2009) Impact of cardiac troponin T N-terminal deletion and phosphorylation on myofilament function. Biochemistry 48:7722-31
Pavlov, Dmitry; Gerson, Jack H; Yu, Tianwei et al. (2003) The regulation of subtilisin-cleaved actin by tropomyosin/troponin. J Biol Chem 278:5517-22
Piroddi, N; Tesi, C; Pellegrino, M A et al. (2003) Contractile effects of the exchange of cardiac troponin for fast skeletal troponin in rabbit psoas single myofibrils. J Physiol 552:917-31
Burkart, Eileen M; Sumandea, Marius P; Kobayashi, Tomoyoshi et al. (2003) Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 278:11265-72
Homsher, E; Nili, M; Chen, I Y et al. (2003) Regulatory proteins alter nucleotide binding to acto-myosin of sliding filaments in motility assays. Biophys J 85:1046-52
Tobacman, Larry S; Nihli, Mahta; Butters, Carol et al. (2002) The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J Biol Chem 277:27636-42
Karibe, A; Tobacman, L S; Strand, J et al. (2001) Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 103:65-71
Strand, J; Nili, M; Homsher, E et al. (2001) Modulation of myosin function by isoform-specific properties of Saccharomyces cerevisiae and muscle tropomyosins. J Biol Chem 276:34832-9
Gordon, A M; Regnier, M; Homsher, E (2001) Skeletal and cardiac muscle contractile activation: tropomyosin ""rocks and rolls"". News Physiol Sci 16:49-55

Showing the most recent 10 out of 31 publications